NCT07419841 2026-03-16A Phase 1 Study of the Safety and Tolerability of CTX-10726Compass TherapeuticsPhase 1 Not yet recruiting70 enrolled
NCT07383506 2026-02-03A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid TumorsCogent Biosciences, Inc.Phase 1 Not yet recruiting90 enrolled
NCT06754761 2025-01-01Human ADME Study of [14C]-Ceralasertib (AZD6738) and Absolute Bioavailability of CeralasertibAstraZenecaPhase 1 Not yet recruiting8 enrolled
NCT06614751 2024-09-27A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR PathwayDanatlas Pharmaceuticals Co., LtdPhase 1 Not yet recruiting112 enrolled